BioGX

What BioGX does

BioGX is a privately held molecular diagnostics company founded in 2007 and headquartered in Birmingham, Alabama, with a wholly owned European subsidiary (BioGX B.V.) in Amsterdam and a manufacturing facility in Dallas, Texas. The company designs, manufactures, and commercializes lyophilized (freeze-dried) real-time PCR reagents under its proprietary Sample-Ready™ platform, in which all assay components — salts, enzymes, primers, and probes — are pre-mixed and freeze-dried in a single tube, enabling room-temperature storage and shipping without cold chain. Its Xfree™ product line extends this concept with extraction-free direct sample-to-answer PCR workflows that eliminate nucleic acid extraction steps. BioGX offers 60+ syndromic multiplex PCR assays across infectious disease categories (antimicrobial resistance, bloodborne, COVID-19, gastrointestinal, meningitis/encephalitis, respiratory, sexual health, urinary tract, women's health, wound), and also markets a proprietary benchtop real-time PCR instrument, the pixl™ platform.

The company serves clinical laboratories, state and regional Departments of Health, food safety laboratories, and pharmaceutical/water quality QC customers. Products are validated on multiple open PCR systems — BD MAX, Applied Biosystems QuantStudio 5 and 7500 Fast Dx, and Bio-Rad CFX96/CFX384 Touch — as well as the proprietary pixl platform. BioGX generates revenue primarily through transactional sales of reagent kits (with recurring reorders), sales of the pixl instrument, and a custom Open Source Reagents (OSR) manufacturing service for laboratories outsourcing Laboratory Developed Test production. Distribution is hybrid: direct enterprise sales via quote-based pricing, plus a global distribution network across multiple countries. The company holds FDA Emergency Use Authorization for its Xfree COVID-19 test, CE-IVD markings for international markets, and operates under cGMP and ISO 13485-certified manufacturing. Leadership includes scientific founders with Cepheid and FDA backgrounds, a President/COO with Abbott Diagnostics and Abbott Molecular tenure, and a VP R&D who previously designed 100+ multiplex PCR products during an eight-year FDA career.

Name

BioGX

Legal name

BioGX, Inc.

Website

https://biogx.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

BioGX is a privately held molecular diagnostics company that develops and manufactures lyophilized real-time PCR reagents and the pixl benchtop PCR platform, serving clinical laboratories, state Departments of Health, food safety, water quality, and pharmaceutical QC customers across more than 60 syndromic multiplex assays.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices) (AFALAEAK)

Keywords

• Molecular diagnostic reagents
• Lyophilized PCR assays
• Syndromic multiplex testing
• Extraction-free PCR kits
• Clinical laboratory reagents

Headquarters

HQ city

Birmingham

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Molecular Diagnostic PCR Reagents: BioGX generates revenue through the sale of lyophilized PCR reagents, including Sample-Ready syndromic multiplexes, Xfree extraction-free assays, and custom PCR assay manufacturing. Products are sold in kit formats with specific reaction counts. Revenue is one-time transactional per kit purchase with recurring reorders.
2. Custom PCR Assay Manufacturing (Open Source Reagents): BioGX offers Open Source Reagents (OSRs) manufacturing service for laboratories developing their own Laboratory Developed Tests (LDTs). Custom-designed reagents are manufactured and lyophilized for specific customer requirements.
3. pixl Real-time PCR Instrument: Sale of the proprietary pixl benchtop real-time PCR platform alongside compatible reagent kits.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

BioGX designs, manufactures, and sells lyophilized real-time PCR reagents and instruments for molecular diagnostics. Its Sample-Ready™ reagents ship and store at ambient temperature and require only water or direct sample addition for testing, while the Xfree™ line eliminates nucleic acid extraction. Products include syndromic multiplex panels (respiratory, gastrointestinal, sexual health, urinary tract, wound, etc.), the proprietary pixl™ PCR platform, CE-IVD and FDA EUA authorized assays, and custom PCR reagent manufacturing for laboratory developed tests.

Product overview

BioGX is a molecular diagnostics company offering lyophilized real-time PCR reagents and instruments for clinical, food safety, water quality, and pharmaceutical QC testing. The product portfolio centers on the proprietary Sample-Ready™ technology platform, which enables all components for a complete RT-PCR test to be lyophilized in a single tube with 'Just Add Water' or direct sample workflow. Core offerings include the Xfree™ extraction-free direct PCR test line (COVID-19, Respiratory, Monkeypox, Sexual Health panels), the pixl™ real-time PCR instrument, and 50+ syndromic multiplexes organized by clinical category (Antimicrobial Resistance, Bloodborne, COVID-19, Gastrointestinal, Immunocompromised/Meningitis/Encephalitis, Nail Fungus, Respiratory, Sexual Health, Urinary Tract, Women's Health, Wound). Products are available as CE-IVD marked reagents for international markets and FDA EUA authorized tests for COVID-19 in the U.S. The company also offers Custom PCR Assays for Laboratory Developed Tests through its Open Source Reagents manufacturing service.

Differentiator

Problem solved

Functional benefit

Brands

• Sample-Ready™: Proprietary lyophilized real-time PCR technology platform enabling reagents to be stored at room temperature and shipped anywhere without refrigeration.
• Xfree™
• pixl™
• Open Source Reagents (OSRs)

Products and services

• Xfree™ COVID-19 Direct RT-PCR Test FDA Emergency Use Authorized extraction-free direct RT-PCR test for SARS-CoV-2 detection. Ships at ambient temperature with no refrigeration required and is available in 96 and 384-well plate formats for clinical laboratories performing COVID-19 diagnostics.
• Xfree™ Respiratory Panel Extraction-free direct RT-PCR test panel including COVID-19, Flu A, Flu B, RSV, Group A Streptococcus, and Mycoplasma pneumoniae. Direct sample addition with lyophilized reagents in single tube format for syndromic respiratory testing in clinical labs.
• Xfree™ Lesion Swab Panel Extraction-free direct PCR assay for lesion swab samples including Monkeypox Virus (Mpox), HSV-1, HSV-2, VZV, and Treponema pallidum (Syphilis), enabling simplified sexual health and lesion pathogen testing.
• Sample-Ready™ Lyophilized PCR Reagents (Open System Reagents) Lyophilized real-time PCR reagents packaged as open system reagents for use with multiple platform types including BD MAX, Applied Biosystems QuantStudio 5, 7500 Fast Dx, and Bio-Rad CFX96/CFX384 Touch. CE-IVD marked products available internationally with universal cycling conditions; stored and shipped at ambient temperature.
• pixl™ Real-time PCR Platform Proprietary benchtop real-time PCR instrument for syndromic testing. Supports Xfree™ extraction-free direct PCR assays with minimal pipetting steps and no extraction reagents required, enabling portable molecular diagnostic workflows.
• Syndromic Multiplex PCR Assays (60+ panel portfolio) Portfolio of 60+ lyophilized real-time PCR syndromic multiplexes covering Antimicrobial Resistance, Bloodborne, COVID-19, Gastrointestinal, Immunocompromised/Meningitis/Encephalitis, Nail Fungus, Respiratory, Sexual Health, Urinary Tract, Women's Health, and Wound categories for clinical laboratories performing molecular infectious disease detection.
• CE-IVD PCR Assays CE-IVD marked Sample-Ready™ PCR assays for international markets, covering respiratory pathogens, sexually transmitted infections, and other infectious disease panels. Sold through BioGX's Global Distribution Network across multiple countries.
• Custom PCR Assays / Open Source Reagents (OSR) Manufacturing Service Custom-designed PCR reagents mixed and lyophilized in one tube for Laboratory Developed Tests (LDTs). Open Source Reagents (OSRs) manufacturing service for laboratories to outsource LDT manufacturing with reagents fine-tuned for any lab setting.
• Food, Water & Pharma QC PCR Tests Molecular testing solutions for food safety (Salmonella, E. coli, Campylobacter and other foodborne pathogens), water quality testing, and pharmaceutical manufacturing quality control using PCR-based detection for applied testing laboratories.
• Candida auris PCR Assay PCR assay for detection of Candida auris, an emerging multi-drug resistant fungal pathogen. Supports State Departments of Health surveillance programs and outbreak response.
• Monkeypox (Mpox) Xfree™ hMPXV PCR Assay Xfree™ hMPXV PCR assay for detection of Monkeypox virus with RNase P control, in extraction-free direct PCR format for clinical and public health laboratories.

Quantifiable outcome

• Direct sample, extraction-free workflow eliminates pre-treatment and nucleic acid extraction steps
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature5 records

Partnerships

One partnership is on record.

• Microbix Biosystems Inc.coreTechnology or Integration · 7 December 2023Microbix and BioGX collaborate on real-time PCR Assays & Controls. Microbix serves as the primary External Quality Controls provider for BioGX's pixl platform and other PCR systems. Nine PROCEEDx FLOQ QAPs are recommended for use with BioGX assays detecting SARS-CoV-2, Influenza A&B, Group A Streptococcus, HSV-1&2, VZV, Treponema pallidum, and Mpox virus. Microbix QAPs are referenced in BioGX Assay Product Inserts.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• BioFire Diagnostics (bioMérieux): BioFire's FilmArray syndromic panels (respiratory, GI, meningitis/encephalitis, bloodstream) define the syndromic multiplex molecular standard. BioGX's large Sample-Ready™ multiplex menu and OSR services compete directly in the syndromic testing workflows FilmArray pioneered.
• Cepheid (bioMérieux): Cepheid's GeneXpert system is the dominant closed-cartridge molecular PCR platform across clinical and public-health labs. It is the most direct competitor to BioGX's open-system PCR reagent strategy, targeting many of the same syndromic infectious-disease use cases (including public-health pathogen surveillance).

Emerging players

• ELITech Group: ELITech manufactures and distributes molecular diagnostic reagents and instruments (e.g., ELITe InGenius, GeneFinder assays) for clinical and applied-testing labs worldwide. Its open-system PCR reagent catalog and OEM reagent services make it a direct comparable to BioGX's Sample-Ready™ and OSR offerings.
• Genetic Signatures: Genetic Signatures sells 3base multiplex molecular diagnostic kits for high-throughput syndromic screening of gastrointestinal, respiratory, and STI pathogens. Its open-platform multiplex PCR reagents overlap with BioGX's syndromic testing menu and menu-expansion value proposition.
• Tetracore: Tetracore develops and manufactures real-time PCR assays and reagents for biodefense, infectious disease, and applied-testing markets, including custom reagent manufacturing services. Its custom molecular reagent OEM and infectious-disease focus make it an emerging comparable in the open-system PCR reagent space.

Broad incumbents

• Abbott Molecular: Abbott's m2000 and Alinity m systems provide real-time PCR infectious-disease testing; Abbott also historically developed FISH and IHC automation in the molecular workflow space. BioGX's open-system reagents and syndromic multiplexing overlap with Abbott's clinical menu strategy, especially in respiratory and STI panels.
• Roche Diagnostics: Roche's cobas Liat and cobas 6800/8800 systems cover point-of-care and high-throughput molecular PCR for infectious disease, while Roche also supplies PCR reagents on its open platforms. BioGX competes in overlapping respiratory, STI, and AMR menu categories on compatible open PCR systems.
• Qiagen: Qiagen offers a broad portfolio of molecular sample-prep and PCR reagents (e.g., QIAstat-Dx syndromic system, custom OEM reagent manufacturing) targeting clinical and applied-testing labs. BioGX's open-system PCR reagents and OSR custom-manufacturing service overlap with Qiagen's reagent and OEM offerings.
• Hologic (Panther Fusion): Hologic's Panther Fusion system is a fully automated, random-access real-time PCR molecular platform offering Aptima and Panther Fusion assays for sexually transmitted infections and respiratory pathogens. BioGX's Xfree™ STI and respiratory panels are alternative open-system options to Panther Fusion's closed menu.

Others

• Microbix Biosystems: Microbix is BioGX's named QC partner, providing PROCEEDx™ FLOQ® QAPs referenced in BioGX assay product inserts for the pixl platform. As a quality-assessment reagent supplier embedded in BioGX's test workflows, Microbix is an ecosystem peer rather than a direct competitor, but the partnership signals peer-level market positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/biogxmolecular
• LinkedInlinkedin.com/company/biogx
• Instagraminstagram.com/biogxmolecular

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioGX